Sirio’s board has approved a potential total investment of up to $40 million for the project SIRIO Pharma (SIRIO) the global nutraceutical contract development and manufacturing organisation (CDMO) announces plans to commence work on a new production site in Chonburi, Thailand. After record revenues during 2023, Sirio announced in May 2024 a[Read More…]
Tag: Sirio Pharma
Navigating regulatory maze primary challenges facing nutraceuticals in Asia
Alex Du, General Manager of the APAC Business Unit at Sirio Pharma Co., Ltd, In Asia, one of the primary challenges is the regulatory complexities across different regions. The rules governing nutraceuticals are not well defined in some areas, making compliance and market entry difficult. Quality control is another potential[Read More…]
Sirio sees surging revenues driven by rapidly rising international sales
Overall turnover has risen to $508m [€469m] during 2023 – up 42.87 per cent year-on-year Sirio Pharma (SIRIO) the global nutraceutical contract development and manufacturing organisation (CDMO) announces record revenues at Vitafoods Europe with international sales reaching near parity with domestic revenues for the first time. The CDMO, which is among the largest[Read More…]
